Levetiracetam

Feb 20, 2020

UCB Full Year Report 2019

Dec 09, 2019

Eisai Presents New Seizure Freedom and Adherence Data Related to Anti-Epileptic Drug FYCOMPA® at the 2019 American Epilepsy Society Annual Meeting

Jan 30, 2019

Epilepsy - Market Analysis, Market Size, Epidemiology, Leading Companies and Competitive Analysis by DelveInsight

Oct 30, 2018

UCB First Nine Months Interim Report 2018: UCB tracking well towards full year financial outlook

Jul 12, 2018

OWP Pharmaceuticals, Twinned with a Not-For-Profit (ROW Foundation) Focuses on Affordable Access to Select Neuro/Psych Neuroscience Drugs

May 14, 2018

UCB Announces BRIVIACT® (Brivaracetam) now Approved by FDA to Treat Partial-onset (Focal) Seizures in Pediatric Epilepsy Patients

Feb 05, 2018

Global 3D Printed Drugs Market Expected to Reach $522 Million by 2030 - Allied Market Research

Nov 09, 2017

Epilepsy - Market Insights, Epidemiology and Market Forecast - 2025